Literature DB >> 26836934

Association Between Occupational Exposures and Sarcoidosis: An Analysis From Death Certificates in the United States, 1988-1999.

Hongbo Liu1, Divya Patel2, Alison M Welch3, Carla Wilson4, Margaret M Mroz3, Li Li5, Cecile S Rose6, Michael Van Dyke7, Jeffrey J Swigris8, Nabeel Hamzeh5, Lisa A Maier9.   

Abstract

BACKGROUND: Sarcoidosis is a disease that is associated with occupational and environmental antigens, in the setting of a susceptible host. The aim of this study was to examine the association between sarcoidosis mortality and previously reported occupational exposures based on sex and race.
METHODS: The decedents enrolled in this study were derived from United States death certificates from 1988-1999. Cause of death was coded according to ICD-9 and ICD-10. The usual occupation was coded with Bureau of the Census Occupation Codes. Mortality odds ratio (MOR) were determined and multiple Poisson regression were performed to evaluate the independent exposure effects after adjustment for age, sex, race and other occupational exposures.
RESULTS: Of the 7,118,535 decedents in our study, 3,393 were identified as sarcoidosis-related, including 1,579 identified as sarcoidosis being the underlying cause of death. The sarcoidosis-related MOR of any occupational exposure was 1.52 (95% CI, 1.35-1.71). Women with any exposure demonstrated an increased MOR compared to women without (MOR 1.65, 95% CI, 1.45-1.89). The mortality risk was significantly elevated in those with employment involving metal working, health care, teaching, sales, banking, and administration. Higher sarcoidosis-related mortality risks associated with specific exposures were noted in women vs men and blacks vs whites.
CONCLUSIONS: Findings of prior occupations and risk of sarcoidosis were verified using sarcoidosis mortality rates. There were significant differences in risk for sarcoidosis mortality by occupational exposures based on sex and race.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  mortality; mortality OR; occupational exposure; sarcoidosis

Mesh:

Substances:

Year:  2016        PMID: 26836934      PMCID: PMC4980546          DOI: 10.1016/j.chest.2016.01.020

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  46 in total

1.  Epidemiologic and clinical observations in sarcoidosis.

Authors:  M M CUMMINGS; E DUNNER; J H WILLIAMS
Journal:  Ann Intern Med       Date:  1959-04       Impact factor: 25.391

2.  A case control etiologic study of sarcoidosis: environmental and occupational risk factors.

Authors:  Lee S Newman; Cecile S Rose; Eddy A Bresnitz; Milton D Rossman; Juliana Barnard; Margaret Frederick; Michael L Terrin; Steven E Weinberger; David R Moller; Geoffrey McLennan; Gary Hunninghake; Louis DePalo; Robert P Baughman; Michael C Iannuzzi; Marc A Judson; Genell L Knatterud; Bruce W Thompson; Alvin S Teirstein; Henry Yeager; Carol J Johns; David L Rabin; Benjamin A Rybicki; Reuben Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2004-09-03       Impact factor: 21.405

3.  Silica-induced apoptosis in alveolar macrophages: evidence of in vivo thiol depletion and the activation of mitochondrial pathway.

Authors:  Shuiying Hu; Hongwen Zhao; Nabil H Al-Humadi; Xuejun J Yin; Joseph K H Ma
Journal:  J Toxicol Environ Health A       Date:  2006-07

4.  Association between exposure to crystalline silica and risk of sarcoidosis.

Authors:  V Rafnsson; O Ingimarsson; I Hjalmarsson; H Gunnarsdottir
Journal:  Occup Environ Med       Date:  1998-10       Impact factor: 4.402

5.  Sarcoidosis diagnoses among U.S. military personnel: trends and ship assignment associations.

Authors:  P Jajosky
Journal:  Am J Prev Med       Date:  1998-04       Impact factor: 5.043

6.  Risk factors for sarcoidosis hospitalization among U.S. Navy and Marine Corps personnel, 1981 to 1995.

Authors:  C McDonough; G C Gray
Journal:  Mil Med       Date:  2000-08       Impact factor: 1.437

7.  Sarcoidosis-related mortality in the United States from 1988 to 2007.

Authors:  Jeffrey J Swigris; Amy L Olson; Tristan J Huie; Evans R Fernandez-Perez; Joshua Solomon; David Sprunger; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2011-02-17       Impact factor: 21.405

8.  Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: The Black Women's Health Study.

Authors:  Yvette C Cozier; Jeffrey S Berman; Julie R Palmer; Deborah A Boggs; Lauren A Wise; Lynn Rosenberg
Journal:  Am J Epidemiol       Date:  2012-09-11       Impact factor: 4.897

9.  Is sarcoidosis related to exposure to pets or the housing conditions? A case-referent study.

Authors:  P Revsbech
Journal:  Sarcoidosis       Date:  1992-09

10.  The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States.

Authors:  M A Judson; A D Boan; D T Lackland
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2012-10       Impact factor: 0.670

View more
  9 in total

Review 1.  How the Frequency and Phenotype of Sarcoidosis is Driven by Environmental Determinants.

Authors:  Manuel Ramos-Casals; Belchin Kostov; Pilar Brito-Zerón; Antoni Sisó-Almirall; Robert P Baughman
Journal:  Lung       Date:  2019-06-12       Impact factor: 2.584

2.  A Novel In Vitro Human Granuloma Model of Sarcoidosis and Latent Tuberculosis Infection.

Authors:  Elliott D Crouser; Peter White; Evelyn Guirado Caceres; Mark W Julian; Audrey C Papp; Landon W Locke; Wolfgang Sadee; Larry S Schlesinger
Journal:  Am J Respir Cell Mol Biol       Date:  2017-10       Impact factor: 6.914

Review 3.  In-silico modeling of granulomatous diseases.

Authors:  Elliott D Crouser
Journal:  Curr Opin Pulm Med       Date:  2016-09       Impact factor: 3.155

4.  Prospective study of body mass index and risk of sarcoidosis in US women.

Authors:  Orianne Dumas; Krislyn M Boggs; Yvette C Cozier; Meir J Stampfer; Carlos A Camargo
Journal:  Eur Respir J       Date:  2017-10-19       Impact factor: 16.671

5.  Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis.

Authors:  Cathryn T Lee; Mary E Strek; Ayodeji Adegunsoye; Alyson W Wong; Deborah Assayag; Gerard Cox; Charlene D Fell; Jolene H Fisher; Andrea S Gershon; Andrew J Halayko; Nathan Hambly; Nasreen Khalil; Martin Kolb; Stacey D Lok; Hélène Manganas; Veronica Marcoux; Julie Morisset; Mohsen Sadatsafavi; Shane Shapera; Teresa To; Pearce Wilcox; Christopher J Ryerson; Kerri A Johannson
Journal:  Respirology       Date:  2022-05-05       Impact factor: 6.175

Review 6.  The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement.

Authors:  Paul D Blanc; Isabella Annesi-Maesano; John R Balmes; Kristin J Cummings; David Fishwick; David Miedinger; Nicola Murgia; Rajen N Naidoo; Carl J Reynolds; Torben Sigsgaard; Kjell Torén; Denis Vinnikov; Carrie A Redlich
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

7.  Sarcoidosis: a prospective observational cohort from Northern Alberta.

Authors:  Dilini Vethanayagam; Jillian Peters; Emad Saad; Kimberley Mulchey; Ashley-Mae Gillson; Brian McNab; Maxine Farr-Jones; Tomasz Hruczkowski; Gregg Blevins; Richard Coulden; Gavin Oudit; Jeremy Beach
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-12-16       Impact factor: 0.670

8.  Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases.

Authors:  Cathryn T Lee; Ayodeji Adegunsoye; Jonathan H Chung; Iazsmin Bauer Ventura; Renea Jablonski; Steven Montner; Rekha Vij; Stella E Hines; Mary E Strek
Journal:  Chest       Date:  2021-02-20       Impact factor: 10.262

Review 9.  Sarcoidosis: An Occupational Disease?

Authors:  L Christine Oliver; Andrew M Zarnke
Journal:  Chest       Date:  2021-06-05       Impact factor: 9.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.